Key result
Ventricular arrhythmia ablation in patients with heart failure and LVADs was associated with reduced VA rates, decreasing median VA burden from 22 to 13 in the post-LVAD cohort.
Why the study?
Does ventricular arrhythmia ablation reduce arrhythmia burden in patients with advanced heart failure and HeartMate II LVADs?
Cohort (n=9)
No
Does ventricular arrhythmia ablation reduce arrhythmia burden in patients with advanced heart failure and HeartMate II LVADs?
Ventricular arrhythmia ablation is associated with reduced arrhythmia burden in patients post-LVAD implantation, with most substrates unrelated to the inflow cannula site.
Answers are grounded in this paper and cite their sources.
VA ablation was associated with reduced VA burden in LVAD patients; hypothesis-generating and requires prospective trials before practice change.
BACKGROUND: Patients with advanced heart failure (HF) are predisposed to ventricular arrhythmias (VAs), particularly following implantation of a left ventricular assist device (LVAD). There is minimal evidence for appropriate management strategies. OBJECTIVES: This study aimed to compare the burden of VA and response to ablation performed either before or following LVAD implantation. METHODS: We created a retrospective cohort of patients who underwent both VA ablation and Heart Mate II (Thoratec, Pleasanton, CA, USA) LVAD implantation at Mayo Clinic (Rochester, MN, USA). Patients were stratified based on whether they underwent VA ablation before (pre-LVAD) or after LVAD (post-LVAD) implantation. Descriptive analyses assessed 6-month arrhythmia burden in relation to LVAD implantation and VA ablation. RESULTS: A total of 9 patients underwent both LVAD implantation and VA ablation. There were 3 and 6 patients, respectively, in the pre-LVAD and post-LVAD cohorts. Among patients in the pre-LVAD cohort, the median number of VAs tended to increase after ablation (9 vs. 72) and decreased after LVAD implantation (72 vs. 63). Similarly among patients in the post-LVAD cohort, the median burden of VAs increased after LVAD implantation (1 vs. 22) and the median burden decreased after ablation (22 vs. 13). Two of 6 patients had substrate related to the LVAD inflow cannula site, while other substrate was not related directly to the cannula. CONCLUSIONS: In patients with progressive HF and LVAD implantation, ablation is associated with reduced VA rates. In LVAD patients, most VAs arise from substrate unrelated to the inflow cannula site.
No takes yet. Share an insight, caveat, or question.
Snipelisky et al. (2016) conducted a cohort in Advanced heart failure with ventricular arrhythmias (n=9). Ventricular arrhythmia ablation vs. Pre-ablation period was evaluated on 6-month arrhythmia burden. Ventricular arrhythmia ablation in patients with heart failure and LVADs was associated with reduced VA rates, decreasing median VA burden from 22 to 13 in the post-LVAD cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: